Skip to main content

CBSTQ · Cannabist Co Holdings Inc. · Financials

Track CBSTQ — free
$0.00 +0.00 (+0.00%) At close · Oct 6
Market Cap
$49,746
Shares
497.46M
Volume · Oct 6 7177 Avg daily vol (3M) 148.4K

Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.

Revenue
$458.72M -10.3%
FY2024 Revenue FY2020–FY2024
Net Income
-$105.89M +39.7%
FY2024 Net Income FY2020–FY2024
Gross Margin
36.69% +1.5pp
FY2024 Gross Margin FY2020–FY2024
Operating Margin
-4.86% +15.7pp
FY2024 Operating Margin FY2020–FY2024
Diluted EPS
-$0.23 +47.7%
FY2024 Diluted EPS FY2020–FY2024
Operating Cash Flow
-$23.38M -412.9%
FY2024 Operating Cash Flow FY2020–FY2024

Chart any reported metric, KPI or segment over time — the full statement history lives here

Line Item TTM FY2024 FY2023 FY2022 FY2021 FY2020
$349.84M $458.72M $511.33M $511.58MG $460.08M $179.5M
$246.59M $290.43M $331.36M $310.16M — —
$103.25M $168.3M $179.97M $201.21M $194.02M $62.14M
— 36.69% 35.2% 39.33% 42.17% 34.62%
$150.9M $188.35M $199.59M $277.33M $232.05M $142.36M
— $11.4M $18.61M $44.53M $26.08M $3.64M
$39.85M $48.98M $62.73M $84.79M $53M $19.65M
— $190.57M $285.21M $617.45M $304.38M $142.36M
-$49.94M -$22.27M -$105.24M -$416.24M -$110.37M -$80.21M
— -4.86% -20.58% -81.36% -23.99% -44.69%
-$10.09M $26.71M -$42.51M -$331.45M -$57.36M -$60.56M
-$76.15M -$39.55M -$63.66M -$16.45M -$36.35M -$55.63M
-$126.09M -$61.82M -$168.9M -$432.69M -$146.71M -$135.85M
$53.31M $43.31M $5.39M -$11.21M $139K -$16.2M
-$179.38M -$105.89M -$175.71M -$416.01M -$146.85M -$119.65M
— -23.08% -34.36% -81.32% -31.92% -66.66%
-$441K $760K $1.43M -$5.48M -$3.76M -$23.86M
— -$105.89M -$175.71M -$416.01M -$143.1M -$95.79M
USD/shares -$0.38 -$0.23 -$0.44 -$1.06 -$0.42 -$0.41
USD/shares -$0.38 -$0.23 -$0.44 -$1.06 -$0.42 -$0.41
shares — 462.5M 402.78M 392.57M 338.75M 232.58M
shares — 462.5M 402.78M 392.57M 338.75M 232.58M
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative. (G): the company's own guidance — a (G) column is a guided period not yet reported; a G marker shows how the reported figure landed against the guided range. Non-GAAP-basis guidance (*) is shown as stated and never judged against GAAP actuals.

Debt Profile

Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.

Reported debt balances

Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.

Reported balanceAs ofAmountSource
Current finance lease liabilities 2025-09-30 USD 3,954,000 10-Q filed 2025-11-10
Current operating lease liabilities 2025-09-30 USD 6,946,000 10-Q filed 2025-11-10
Long-term debt, including current maturities 2025-09-30 USD 299,252,000 10-Q filed 2025-11-10
Related accounting measures — not additional borrowing

Carrying amounts can reflect issuance costs or discounts. Differences between these measures are not necessarily repayments due within a year.

Current portion of long-term debt
USD 594,000
Noncurrent debt carrying amount
USD 298,658,000
Noncurrent finance lease liabilities 2025-09-30 USD 34,960,000 10-Q filed 2025-11-10
Noncurrent operating lease liabilities 2025-09-30 USD 97,936,000 10-Q filed 2025-11-10
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.

Covenants

Covenant terms have not yet been verified for this profile.

The balance figures do not establish whether covenants apply or whether the company complies with them.

Loans, facilities and notes

The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.

Price & Valuation

Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.

Valuation

EV/Revenue
—
Drug Manufacturers - Specialty & Generic median 1.97×
EV/EBIT
—
Drug Manufacturers - Specialty & Generic median 16.44×
P/E (TTM)
—
Drug Manufacturers - Specialty & Generic median 16.62×

Valuation over time computed as of each quarter's filing date

Revenue Breakdown

Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.

Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.

By Product & Service (USD)

Component FY2024 FY2023 FY2022 FY2021 FY2020
Dispensary $389,287,000 $448,771,000 $438,879,000 $376,582,000 $164,011,000
Cultivation And Wholesale $69,435,000 $62,526,000 $72,580,000 $83,180,000 $15,347,000
Columbia Cares National Credit Card $0 $4,064,000 $4,520,000 $4,524,000 —
Manufactured Product Other $0 $30,000 $119,000 $318,000 $145,000